News

May 29, 2020May 29, 2020

Cell Therapy ATA188 Safely Easing Disability in Progressive MS, Trial Reports

News

Atara Biotherapeutics‘ cell-based therapy ATA188 is safe and well-tolerated in people with progressive forms of multiple sclerosis (MS), and induces a sustained reduction in disability in a dose-dependent manner, ... Read more

May 29, 2020May 29, 2020

Ofatumumab Lowers B-cell Counts and Helps Relapsing MS Patients Reach NEDA, Data Show

News

Ofatumumab (OMB157) elicits a strong and fast reduction in the levels of circulating immune cells in people with relapsing forms of multiple sclerosis (MS), effectively helping to stop disease ... Read more

May 28, 2020May 28, 2020

MS Diagnostic Criteria Should Be Changed to First Rule Out NMOSD, Study Says

News

Diagnostic guidelines for multiple sclerosis (MS) should be amended to first rule out the presence of neuromyelitis optica spectrum disorder (NMOSD), a neurological inflammatory disease that also affects the ... Read more

May 28, 2020May 28, 2020

World MS Day, May 30, Goes On … But Online

Covid-19, News

Despite the COVID-19 pandemic, there are many ways to participate in World MS Day 2020 on May 30, set aside to raise awareness about the neurodegenerative disorder that affects more than 2.3 ... Read more

May 27, 2020May 28, 2020

Zeposia Receives European Commission Approval for Adults with Active RRMS

News, Zeposia

The European Commission (EC) has approved Zeposia (ozanimod) for the treatment of adults with relapsing-remitting multiple sclerosis (RRMS) who have active disease based on clinical or imaging features. The ... Read more

May 27, 2020May 27, 2020

Higher Blood NfL Levels Predict Worse Disability Over Time in MS, Study Suggests

News

Higher blood levels of the neurofilament light chain (NfL) protein at diagnosis are predictive of worse disability over time in people with multiple sclerosis (MS), a large population study from ... Read more

May 27, 2020May 27, 2020

Air Pollution of Urban Life Raises MS Risk, Study from Italy Suggests

News

Exposure to air pollutants, particularly to fine particle pollutants (2.5 micrometers or less in diameter), seems to increase a person’s risk of multiple sclerosis (MS), a study from northern Italy ... Read more

May 26, 2020May 27, 2020

Evobrutinib Lowers MS Relapse Rates Over 2 Years of Use, Trial Data Show

News

Note: This story was updated May 27, 2020, to note a change in the protocol of the EVOLUTION trials, which are now comparing evobrutinib with Aubagio, rather than Avonex, ... Read more

May 26, 2020May 26, 2020

MS Association of America Opens COVID-19 Webinars, Other Resources to Community

News

The Multiple Sclerosis Association of America (MSAA) is opening its resources to people with multiple sclerosis (MS) during COVID-19, including a webinar series on the pandemic and easier access to ... Read more

May 22, 2020May 22, 2020

MedTech Breakthrough Cites RxMx and Roche for MS Patient App

News

For a comprehensive support app developed for multiple sclerosis (MS) patients, RxMx and Roche have won the Patient Engagement Innovation Award from Medtech Breakthrough. The fourth annual awards program recognized top ... Read more

May 22, 2020May 22, 2020

Cell Transplant Restores Myelin Production in Brains of Adult Mice in MS Model

News

Human glial progenitor cells — forerunners of nerve cells that protect and support neurons — transplanted into adult mice in a model of multiple sclerosis (MS) were seen to ... Read more

May 21, 2020May 21, 2020

Higher Risk of Vascular Disease Among MS Patients in the UK, Population-based Study Reveals

News

People in the United Kingdom (U.K.) with multiple sclerosis (MS) have an increased risk of vascular disease affecting the heart and brain that is not accounted for by traditional ... Read more

May 21, 2020May 21, 2020

Learning Physical Task Seen to Trigger Myelin Repair in MS Mouse Model

News

Movements that are an act of “learning” motor tasks after lesions appear in the protective myelin sheath of neurons seem to induce both new and existing oligodendrocytes — the cells ... Read more

May 20, 2020May 20, 2020

Biogen Presents Update on its MS Therapeutic Portfolio

News

Biogen has released new data on several of its therapies for multiple sclerosis (MS), including Vumerity (diroximel fumarate), Tecfidera (dimethyl fumarate), and Tysabri (natalizumab). The data — six presentations ... Read more

May 20, 2020May 20, 2020

Glatopa Shows Efficacy Similar to Copaxone, Study in Real-world Use Finds

News

Glatopa, a generic form of Copaxone, is as effective as the brand-name medication in terms of disease outcomes and has similar healthcare-related costs in real-world use in patients with relapsing multiple ... Read more

May 19, 2020May 20, 2020

MS Patients Have More Aluminum Content in Their Brains Than Those Without Neurodegenerative Conditions, Study Finds

News

People with multiple sclerosis (MS) and other neurological diseases have a significantly higher aluminum content in their brains than those with no known neurological impairment and no identifiable neurodegenerative ... Read more

May 19, 2020May 19, 2020

Memory Immune Cells Play Key Role in Advanced MS, Study Suggests

News

In the brains of people with advanced multiple sclerosis (MS), memory immune cells reside in the brain tissue rather than entering through the bloodstream, a new study suggests. The ... Read more

May 18, 2020May 18, 2020

Blocking Monocytes from Nervous System Eases MS Severity, Early Study Finds

News

Targeting the MOSPD2 protein may prevent immune cells known as monocytes from entering the central nervous system (CNS), which may significantly ease brain inflammation and myelin damage in multiple sclerosis (MS), a ... Read more

May 18, 2020May 22, 2020

National MS Society Expert Panel Offers Guidelines for Regular Exercise

News

Healthcare providers should encourage everyone with multiple sclerosis (MS) to engage in regular exercise and keep physically active, new guidelines based on an expert panel convened by the National ... Read more

May 15, 2020May 18, 2020

EBV Infections Evident in All 901 MS Patients in German Study

News

Supporting evidence that infection with Epstein-Barr virus (EBV) could be one of the root causes of multiple sclerosis (MS), a recent study found all of its 901 early disease patients carry ... Read more

May 15, 2020May 15, 2020

Mindfulness Training Seen to Aid Cognitive, Emotional Well-being in Pilot Study

Covid-19, News

Four weeks of mindfulness meditation helped to improve thinking skills and a sense of emotional balance in people with multiple sclerosis (MS), and to a greater extent than cognitive ... Read more

May 14, 2020May 14, 2020

Progressive MS Linked to Faster Retinal Atrophy, Study Shows

News

People with progressive forms of multiple sclerosis (MS) have faster and disease-modifying therapy (DMT)-resistant retinal atrophy (thinning), compared to those with relapsing-remitting MS (RRMS), a study shows. Data also highlighted ... Read more

May 14, 2020May 15, 2020

FDA Grants Breakthrough Device Designation to Helius’ PoNS Device

News

The U.S. Food and Drug Administration (FDA) has granted breakthrough device designation to Helius Medical Technologies’ portable neuromodulation stimulator (PoNS) for the treatment of walking impairments in multiple sclerosis ... Read more

May 13, 2020May 13, 2020

MS Patient Registry for US Veterans Open to Researchers and Doctors

News

A patient registry of multiple sclerosis (MS) among veterans of the U.S. military has been created to allow for better clinical management of these people and to inform future ... Read more

May 13, 2020May 13, 2020

Ian Duncan Awarded 2020 Dystel Prize for Discoveries in Myelin Repair

News

Neuroscientist Ian D. Duncan has been awarded the 2020 John Dystel Prize for Multiple Sclerosis Research for work that advanced understanding of how myelin, the protective sheath surrounding nerve cells, ... Read more

May 12, 2020May 12, 2020

Spasticity Scales May Not Reflect Sativex Benefits in MS Patients, Study Suggests

News

Sativex (nabiximols) eases spasticity-associated symptoms in multiple sclerosis (MS) patients, including those with no significant improvements in a validated spasticity scale, according to a large study from Italy. The findings support ... Read more

May 12, 2020May 18, 2020

COVID-19 May Not Be Severe in MS Patients, Early Data from Italy Suggest

Covid-19, News

People with multiple sclerosis (MS) may not be at higher risk of developing a severe COVID-19 infection, according to preliminary data from patients in Italy. “At the moment, these ... Read more

May 11, 2020May 11, 2020

MMJ Can Ship Cannabis Products to US for Clinical Testing, Agencies Say

News

MMJ International Holdings announced that it has been given clearance to ship its cannabis-based products to the U.S. for use in future clinical trials of potential cannabis-based treatment for multiple sclerosis ... Read more

May 11, 2020May 11, 2020

FDA Clears Nurocheck, Portable Device to Quickly Assess Brain Health

News

A portable device that can quickly measure electrical activity in the brain and relay it to doctors via a smartphone app, called the Nurochek system, has been cleared by the United ... Read more

May 8, 2020May 8, 2020

ZyVersa’s IC 100 Reduced Inflammation in MS Mouse Model, Study Finds

News

IC 100, a monoclonal antibody by ZyVersa Therapeutics that prevents the assembly of inflammasomes — a pro-inflammatory cellular complex — lessened inflammation and halted disease progression in multiple sclerosis (MS), a study ... Read more

May 8, 2020May 8, 2020

‘Transcient’ Damage to CNS Seen with Chemotherapy Used in Stem Cell Transplants for MS

News

A high-dose chemotherapy combination given to wipe out the immune system before its rescue with autologous hematopoietic stem cell transplant (aHSCT) can cause “transient” damage to neurons and supporting cells of ... Read more

May 7, 2020May 7, 2020

Long-term Gilenya Use Helps Delay Disability in Relapsing MS, 10-year Study Reports

News

Read more

May 7, 2020May 21, 2020

NurOwn May Curb Damaging Neuroinflammation in MS, Study Finds

Covid-19, News

NurOwn, believed to have neuroprotective and repairing effects, may also be able to curb the damaging immune responses that contribute to multiple sclerosis (MS) progression, a recent study found. This newly ... Read more

May 6, 2020May 6, 2020

Immune Cell microRNAs Are Potential MS Biomarkers, Study Suggests

News

Read more

May 6, 2020May 12, 2020

COVID-19 Infection Not Severe in PPMS Patient on Ocrevus, Case Report Finds

Covid-19, News

Read more

May 5, 2020May 12, 2020

Belong.Life Launches App to Support MS Patients and Healthcare Professionals

News

Read more

May 5, 2020May 6, 2020

FDA Approves Bafiertam, Tecfidera Bioequivalent, for Relapsing MS

News

Read more

May 4, 2020May 4, 2020

Pain, Fatigue in MS and Neuromyelitis Optica Spectrum Compared in Study

News

Read more

May 4, 2020May 4, 2020

Ublituximab Phase 2 Data Support Safety, Efficacy in Relapsing MS

News

Read more

May 1, 2020May 12, 2020

MS Society of Canada Launches Virtual Fundraising Campaign

Covid-19, News

The Multiple Sclerosis Society of Canada is launching a virtual effort that seeks to connect multiple sclerosis (MS) communities across the country and raise funds for research in observance ... Read more